1.Just, M, Berger, R, Luescher, D. Live varicella vaccine in healthy individuals. Postgrad Med J 1985; 61 (suppl 4): 129–32.
2.Plotkin, SA. Varicella vaccine: a point of decision. Pediatrics 1986; 78: 705–7.
3.McLean, G. Compulsory vaccination. Aust Fam Phys 1988; 17: 12.
4.Starr, SE. Status of varicella vaccine for healthy children. Pediatrics 1989; 84: 1097–9.
5.Garnett, GP, Grenfell, BT. The epidemiology of varicella-zoster virus: a mathematical model. Epidemiol Infect 1992; 108: 495–511.
6.Preblud, SR, Orenstein, WA, Bart, KJ. Varicella: clinical manifestations, epidemiology and health impact in children. Pediat Infect Dis 1984; 3: 505–9.
7.London, WP, Yorke, JA. Recurrent outbreaks of measles, chickenpox and mumps. I. Seasonal variation in contact rates. Am J Epidemiol 1973; 98: 453–68.
8.Olsen, LF, Truty, GL, Schaffer, WM. Oscillations and chaos in epidemics: a nonlinear dynamic study of six childhood diseases in Copenhagen. Denmark. Theoret Pop Biol 1988; 33: 344–70.
9.Gordon, JE.Chickenpox: An epidemiological review. Am J Med Sci 1962; 244: 362–85.
10.Palmer, SR, Caul, EO, Donald, DEK, Wantes, W, Tillett, H. An outbreak of shingles. Lancet 1985; ii: 1108–10.
11.Pallett, AP, Nicholls, MWN. Varicella-zoster: reactivation or reinfection? Lancet 1986; i: 160.
12.Wilson, JB. Thirty-one years of herpes-zoster in a rural practice. Br Med J 1986; 293: 1349–51.
13.Sraus, SE, Ostrove, JM, Ichauspe, G. et al. Varicella-zoster virus infections. Biology, natural history, treatment and prevention. Ann Intern Med 1988; 108: 221–37.
14.McNamara, MP, LaCrosse, S, Piering, WF, Rytel, MW. Exogenous reinfection with varicella–zoster virus. New Eng J Med 1987; 317: 511.
15.Hope-Simpson, RE. The nature of herpes-zoster: a long-term study and a new hypothesis. Proc Roy Soc Med 1965; 58: 9–20.
16.Arvin, AM, Celine, MK, Wittek, AE. Immunologic evidence of reinfection with varicella-zoster virus. J Infect Dis 1983; 148: 200–5.
17.Hellgren, L, Hersle, K. A statistical and clinical study of herpes-zoster. Geront Clin 1966; 8: 70–6.
18.Ikada, J, Kayami, K, Yamamoto, Y. Varicella may protect against zoster. Lancet 1973; ii: 1276.
19.McGregor, RM. Herpes-zoster, chickenpox and cancer in general practice. Br Med J 1957; i: 84–7.
20.Shargorodskaya, VA, Baronin, AV. Some epidemiological peculiarities of the chickenpox and herpes-zoster spread. Zh Mikrobiol Epidemiol Immunobiol 1978; 11: 121–4.
21.Stojie, P. Neke epideioloske karakteristike varicele. Vojnosanit Pregl 1982; 39: 194–7.
22.Fleming, DM, Norbury, CA, Crombie, DL. Annual and seasonal variation in the incidence of common diseases. Twenty-three years experience of the Weekly Returns Service of the Royal College of General Practitioners. Occasional paper. The Royal College of General Practitioners 1991; 53: 5–7.
23.Joseph, CA, Noah, ND. Epidemiology of chickenpox in England and Wales, 1967–1985. Br Med J 1988; 296: 673–6.
24.Anderson, RM, Grenfell, BT, May, RM. Oscillatory fluctuations in the incidence of infectious disease and the impact of vaccination: time series analysis. J Hyg 1984; 96: 305–33.
25.Chatfield, C. The analysis of time series theory and practice. London: Chapman and Hall, 1989.
26.Department of Education and Science. Statistics of schools in England – January 1986. Statistical Bulletin, London: Elizabeth House, 1987.
27.Andre, FE. Worldwide experience with the Oka-strain live varicella vaccine. Postgrad Med J 1985; 61 (suppl 4): 113–20.
28.Takahashi, M, Kamiya, H, Baba, K, Asano, Y, Ozaki, T, Horiuchi, K. Clinical experience with Oka live varicella vaccine in Japan. Postgrad Med J 1985; 61 (suppl 4): 61–7.
29.Englund, JA, Suarez, CS, Kelly, J, Tate, DY, Balfour, HH. Placebo-controlled trial of varicella vaccine given with or after measles–mumps–rubella vaccine. J Pediatr 1989; 114: 37–44.
30.Brunell, PA, Taylor-Wiedeman, J, Geiser, CF, Frierson, L, Lydick, E. Risk of herpes-zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics 1986; 77: 53–6.
31.Lawrence, R, Gershon, AA, Holzman, R et al. , The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med 1988; 302: 450–3.
32.Yabuuchi, H, Baba, K, Tsuda, N et al. , A live varicella vaccine in a pediatric community. Biken J 1984; 27: 43–9.
33.Takahashi, M. Chickenpox virus. Adv in Vir Res 1983; 28: 285–348.
34.Anderson, RM, May, RM. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J Hyg 1985; 94: 365–436.
35.Grenfell, BT, Anderson, RM. Pertussis in England and Wales: An investigation of transmission dynamics and control by mass vaccination. Proc R Soc Lond 1989; B236: 213–52.
36.Anderson, RM, May, RM. Vaccination and herd immunity to infectious disease. Nature 1985; 318: 323–9.
37.Hope-Simpson, RE. Infectiousness of communicable diseases in the household. Lancet 1952; ii: 1299.
38.Davie, CE, Hutt, SJ, Vincent, E, Mason, M. The young child in the home. Windsor: Nfer-Nelson, 1984.
39.Burke, BL, Steele, RW, Beard, OW, Wood, JS, Cain, TD, Marmer, DJ. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982; 142: 291–3.
40.Bannister, P, Crosse, B. Severe herpes-zoster infection in the United Kingdom: experience in a regional infectious disease unit. J Roy Soc Med 1989; 82: 145–6.
41.Preblud, SR, Orenstein, WA, Kaplan, JP, Bart, KJ, Hinman, AR. A benefit-cost analysis of a childhood varicella vaccine programme. Postgrad Med J 1985; 61 (suppl. 4): 17–22.
42.Preblud, SR. Age specific risks of varicella complications. Pediatrics 1981; 68: 14–7.